Shows
BioBossHelen Torley: CEO of Halozyme TherapeuticsHelen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.2024-03-2539 min
BioBreakthroughs#19 - Dr. Helen Torley, President & CEO at HalozymeJoin us on the latest episode! Our Guest: Dr. Helen Torley, President & CEO at HalozymeWhat you'll get out of this episode:Introduction to Dr. Helen Torley, CEO and president of Halozyme.Halozyme's mission to reduce treatment burdens for patients.The revolutionary Enhanze technology: Transforming IV infusions to subcutaneous injections.The significant impact of Halozyme's innovations on healthcare systems.The power of partnerships in driving Halozyme's success.To learn more about Halozyme: https://halozyme.com/Our sponsors for this episode are:Sage Growth Partners https://sage-growth.com/#Halozyme #InnovationInHealthcare...2023-10-0414 min
Life Science SuccessDr. Helen Torley - President and CEO of HalozymeSend us a textIn this episode of Life Science Success, my guest is Dr. Helen Torley. Dr. Torley is the President and CEO of Halozyme. Halozyme's innovative and disruptive solutions provide new therapeutic options that could significantly improve the patient experience by changing how treatments are delivered. Dr. Helen Torley, CEO of Halozyme, discusses the company's dedication to improving patient experiences and outcomes through their research and development of monoclonal antibodies and small molecules. Halozyme places a strong emphasis on corporate culture, including cross-functional collaboration and community outreach. Dr. Torley shares how the book "The Fi...2023-07-2332 min
TechNation Radio PodcastEpisode 20-17 A 15-minute COVID-19 Detector ???On this week’s Tech Nation, David Ludvigson, President & CEO of Nanomix, talks about making their 15-minute, handheld testing device COVID-19 ready. Then Tech Nation Health Chief Correspondent Dr. Daniel Kraft sees the rise of the Maker Movement, especially now with so many people sheltering in place. And Helen Torley, President & CEO of Halozyme Therapeutics, talks about their efforts to move the time it takes IV drugs from hours down to minutes – current testing is in breast cancer in women and multiple myeloma.2020-04-2259 minTechNation Radio PodcastEpisode 19-51 Chernobyl – Then and NowOn this week’s Tech Nation, part I of a two-part series on Chernobyl: Then and Now. Journalist Adam Higginbotham, author of “Midnight in Chernobyl”, recounts what exactly happened at the time of the accident. Later in the show, Vincent Keunen, the Founder and CEO of Andaman7, describes a new app to collect and manage your own medical records, and Helen Torley of Halozyme returns to talk about a technology which reduces the time for infusion therapy.2019-12-2059 min
TechNation Health PodcastEpisode 19-11 Part I – Chernobyl: Then and NowOn this week’s Tech Nation, part I of a two-part series on Chernobyl: Then and Now. Journalist Adam Higginbotham, author of “Midnight in Chernobyl”, recounts what exactly happened at the time of the accident. Later in the show, Vincent Keunen, the Founder and CEO of Andaman7, describes a new app to collect and manage your own medical records, and Helen Torley of Halozyme returns to talk about a technology which reduces the time for infusion therapy.2019-03-1359 min
BioTech Nation Radio PodcastEpisode 19-11 Part I – Chernobyl: Then and NowOn this week’s Tech Nation, part I of a two-part series on Chernobyl: Then and Now. Journalist Adam Higginbotham, author of “Midnight in Chernobyl”, recounts what exactly happened at the time of the accident. Later in the show, Vincent Keunen, the Founder and CEO of Andaman7, describes a new app to collect and manage your own medical records, and Helen Torley of Halozyme returns to talk about a technology which reduces the time for infusion therapy.2019-03-1359 min
TechNation Radio PodcastEpisode 19-11 Part I – Chernobyl: Then and NowOn this week’s Tech Nation, part I of a two-part series on Chernobyl: Then and Now. Journalist Adam Higginbotham, author of “Midnight in Chernobyl”, recounts what exactly happened at the time of the accident. Later in the show, Vincent Keunen, the Founder and CEO of Andaman7, describes a new app to collect and manage your own medical records, and Helen Torley of Halozyme returns to talk about a technology which reduces the time for infusion therapy.2019-03-1359 minTechNation Health PodcastEpisode 19-10 Guy Kawasaki – Lessons from a LifeOn this week’s Tech Nation, Guy Kawasaki, the chief evangelist for Canva, and former chief evangelist of Apple, looks back on his life in “Wise Guy … Lessons from a Life”. Then Pat Condo, CEO of NTENT, describes how our world is changing now that we can speak to the tech around us. Helen Torley, President and CEO of Halozyme, explores how we might fight different aspects of a cancer, making existing cancer treatments more effective. Its first target – pancreatic cancer, with other cancers soon to follow.2019-03-0659 minBioTech Nation Radio PodcastEpisode 19-10 Guy Kawasaki – Lessons from a LifeOn this week’s Tech Nation, Guy Kawasaki, the chief evangelist for Canva, and former chief evangelist of Apple, looks back on his life in “Wise Guy … Lessons from a Life”. Then Pat Condo, CEO of NTENT, describes how our world is changing now that we can speak to the tech around us. Helen Torley, President and CEO of Halozyme, explores how we might fight different aspects of a cancer, making existing cancer treatments more effective. Its first target – pancreatic cancer, with other cancers soon to follow.2019-03-0659 minTechNation Radio PodcastEpisode 19-10 Guy Kawasaki – Lessons from a LifeOn this week’s Tech Nation, Guy Kawasaki, the chief evangelist for Canva, and former chief evangelist of Apple, looks back on his life in “Wise Guy … Lessons from a Life”. Then Pat Condo, CEO of NTENT, describes how our world is changing now that we can speak to the tech around us. Helen Torley, President and CEO of Halozyme, explores how we might fight different aspects of a cancer, making existing cancer treatments more effective. Its first target – pancreatic cancer, with other cancers soon to follow.2019-03-0659 min
Paper TalkPat & Peter GentenaarToday I’m talking with husband and wife Pat Gentenaar Torley & Peter Gentenaar in the town of Delft in The Netherlands. Peter & Pat met in the late 60’s at the California College of Arts & Crafts (now California College of the Arts) in Oakland and settled in the Netherlands shortly afterwards. Peter talks about how the struggle to make three dimensional prints led him to envision making his own paper, and how an introduction to commercial papermaking at the Royal Dutch Paper Factory got him started. Pat talks about how studying fiber arts at CCA with well-known fiber artist Trude Gueromonprez ulti...2018-05-1852 min
Radio Corax 95.9CAPTCHA Radio Show #16 & #17: Conference-RadioIn dieser Live-Sendung zur Konferenz des Projektes CAPTCHA liegt ein Schwerpunkte auf dem Archiv von FEM-FM, einem feministischen Aktionsradio in UK welches in der Sendung vorgestellt wird.Daneben gab es Besuch von NearMedia aus Dublin, welche ein aktuelles lokales oral-history-Projekt vorstellten. Neben den Besonderheiten der „Erinnerung von unten“ berichteten sie auch über ihre derzeitgen Pläne zum Thema Archivierung (in englisch).Die Frage nach einem/einigen historischen Moment/en des Projektes CAPTCHA im Jahr 2013 an Beteiligte zu Beginn des Jahres 2014 wurde sehr unterschiedlich beantwortet. (in englisch)Dagmar Brunow (Universität Växjö, Sweden; FSK – Ham...2015-06-222h 49Radio Corax 95.9CAPTCHA Radio Show #5: Archiving for the community and for the publicIn dieser Sendung gibt es den zweiten Teil eines Gesprächs mit Helen Hahmann zu hören, der Projektkoordinatorin von CAPTCHA. Gesprochen wird sowohl über die Besonderheiten eines möglichen zukünftigem Archivs als auch die Schwierigkeiten derzeitiger Methoden. Dabei beginnen die Gesprächspartner leicht zu philosophieren und begeben sich auf die Suche nach einem Bündel an Fragen.Der zweite Teil der Sendung ist ein Einblick in die Archivmethoden öffentlich-rechtlicher Rundfunkarchive. Zu Gast war Oli Loewe, der von seinen Erfahrungen beim Bayerischen Rundfunk berichtete. Im Gespräch danach berichtete er von einer möglichen Entwicklungswege von Archiven...2014-09-1756 min